QuidelOrtho Corporation (QDEL)
USD 42.46
(-1.32%)
USD 42.46
(-1.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.55 Billion USD | -9.28% |
| 2022 | 3.92 Billion USD | 682.66% |
| 2021 | 501.01 Million USD | -6.95% |
| 2020 | 538.46 Million USD | 53.39% |
| 2019 | 351.04 Million USD | -7.81% |
| 2018 | 380.78 Million USD | -46.23% |
| 2017 | 708.14 Million USD | 277.44% |
| 2016 | 187.62 Million USD | -0.11% |
| 2015 | 187.82 Million USD | -9.06% |
| 2014 | 206.53 Million USD | 331.69% |
| 2013 | 47.84 Million USD | 14.27% |
| 2012 | 41.86 Million USD | -55.22% |
| 2011 | 93.5 Million USD | -8.39% |
| 2010 | 102.07 Million USD | 147.47% |
| 2009 | 41.24 Million USD | 74.98% |
| 2008 | 23.57 Million USD | -9.81% |
| 2007 | 26.13 Million USD | 9.94% |
| 2006 | 23.77 Million USD | -10.65% |
| 2005 | 26.6 Million USD | 18.21% |
| 2004 | 22.5 Million USD | -18.59% |
| 2003 | 27.64 Million USD | 39.36% |
| 2002 | 19.83 Million USD | -9.77% |
| 2001 | 21.98 Million USD | -7.34% |
| 2000 | 23.72 Million USD | 0.0% |
| 1998 | 7.9 Million USD | -27.52% |
| 1997 | 10.9 Million USD | 53.52% |
| 1996 | 7.1 Million USD | -6.58% |
| 1995 | 7.6 Million USD | -28.3% |
| 1994 | 10.6 Million USD | 0.0% |
| 1993 | 10.6 Million USD | 2.91% |
| 1992 | 10.3 Million USD | 7.29% |
| 1991 | 9.6 Million USD | -38.06% |
| 1990 | 15.5 Million USD | 142.19% |
| 1989 | 6.4 Million USD | 3.23% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.51 Billion USD | 3.54% |
| 2024 Q1 | 3.39 Billion USD | -4.54% |
| 2023 Q4 | 3.55 Billion USD | -0.43% |
| 2023 Q2 | 3.54 Billion USD | -6.41% |
| 2023 Q1 | 3.79 Billion USD | -3.33% |
| 2023 FY | 3.55 Billion USD | -9.28% |
| 2023 Q3 | 3.57 Billion USD | 0.69% |
| 2022 Q4 | 3.92 Billion USD | 1.58% |
| 2022 FY | 3.92 Billion USD | 682.66% |
| 2022 Q2 | 3.9 Billion USD | 475.46% |
| 2022 Q1 | 678.2 Million USD | 35.37% |
| 2022 Q3 | 3.86 Billion USD | -1.09% |
| 2021 FY | 501.01 Million USD | -6.95% |
| 2021 Q4 | 501.01 Million USD | 6.08% |
| 2021 Q1 | 607.65 Million USD | 12.85% |
| 2021 Q2 | 396.57 Million USD | -34.74% |
| 2021 Q3 | 472.31 Million USD | 19.1% |
| 2020 Q2 | 361.22 Million USD | -0.1% |
| 2020 Q4 | 538.46 Million USD | 34.58% |
| 2020 FY | 538.46 Million USD | 53.39% |
| 2020 Q1 | 361.56 Million USD | 3.0% |
| 2020 Q3 | 400.11 Million USD | 10.77% |
| 2019 Q3 | 333.35 Million USD | -0.85% |
| 2019 FY | 351.04 Million USD | -7.81% |
| 2019 Q2 | 336.21 Million USD | -24.47% |
| 2019 Q1 | 445.15 Million USD | 16.9% |
| 2019 Q4 | 351.04 Million USD | 5.31% |
| 2018 FY | 380.78 Million USD | -46.23% |
| 2018 Q1 | 534.99 Million USD | -24.45% |
| 2018 Q2 | 394.59 Million USD | -26.24% |
| 2018 Q3 | 405.43 Million USD | 2.75% |
| 2018 Q4 | 380.78 Million USD | -6.08% |
| 2017 FY | 708.14 Million USD | 277.44% |
| 2017 Q4 | 708.14 Million USD | 263.27% |
| 2017 Q1 | 184.37 Million USD | -1.73% |
| 2017 Q2 | 185.94 Million USD | 0.85% |
| 2017 Q3 | 194.93 Million USD | 4.83% |
| 2016 Q1 | 180.35 Million USD | -3.98% |
| 2016 FY | 187.62 Million USD | -0.11% |
| 2016 Q4 | 187.62 Million USD | 4.38% |
| 2016 Q3 | 179.75 Million USD | 1.75% |
| 2016 Q2 | 176.66 Million USD | -2.05% |
| 2015 FY | 187.82 Million USD | -9.06% |
| 2015 Q4 | 187.82 Million USD | -5.91% |
| 2015 Q2 | 199.09 Million USD | -2.28% |
| 2015 Q1 | 203.74 Million USD | -1.35% |
| 2015 Q3 | 199.62 Million USD | 0.27% |
| 2014 Q1 | 46.41 Million USD | -2.99% |
| 2014 Q2 | 38.66 Million USD | -16.69% |
| 2014 FY | 206.53 Million USD | 331.69% |
| 2014 Q3 | 50.36 Million USD | 30.24% |
| 2014 Q4 | 206.53 Million USD | 310.1% |
| 2013 Q1 | 38.65 Million USD | -7.67% |
| 2013 FY | 47.84 Million USD | 14.27% |
| 2013 Q4 | 47.84 Million USD | -7.17% |
| 2013 Q3 | 51.53 Million USD | 12.99% |
| 2013 Q2 | 45.61 Million USD | 17.99% |
| 2012 FY | 41.86 Million USD | -55.22% |
| 2012 Q4 | 41.86 Million USD | -16.44% |
| 2012 Q1 | 52.91 Million USD | -43.41% |
| 2012 Q2 | 48.75 Million USD | -7.87% |
| 2012 Q3 | 50.1 Million USD | 2.78% |
| 2011 Q1 | 79.94 Million USD | -21.68% |
| 2011 Q4 | 93.5 Million USD | 2.81% |
| 2011 FY | 93.5 Million USD | -8.39% |
| 2011 Q3 | 90.95 Million USD | 25.05% |
| 2011 Q2 | 72.73 Million USD | -9.02% |
| 2010 Q3 | 102.26 Million USD | -2.91% |
| 2010 Q4 | 102.07 Million USD | -0.19% |
| 2010 FY | 102.07 Million USD | 147.47% |
| 2010 Q1 | 112.18 Million USD | 181.19% |
| 2010 Q2 | 105.33 Million USD | -6.1% |
| 2009 FY | 41.24 Million USD | 74.98% |
| 2009 Q1 | 18.27 Million USD | -22.46% |
| 2009 Q2 | 18.33 Million USD | 0.28% |
| 2009 Q3 | 31.68 Million USD | 72.88% |
| 2009 Q4 | 39.89 Million USD | 25.9% |
| 2008 Q4 | 23.57 Million USD | -1.98% |
| 2008 FY | 23.57 Million USD | -9.81% |
| 2008 Q2 | 20.48 Million USD | -11.86% |
| 2008 Q3 | 24.04 Million USD | 17.38% |
| 2008 Q1 | 23.24 Million USD | -11.05% |
| 2007 Q2 | 20.84 Million USD | -1.32% |
| 2007 FY | 26.13 Million USD | 9.94% |
| 2007 Q4 | 26.13 Million USD | 17.93% |
| 2007 Q3 | 22.16 Million USD | 6.3% |
| 2007 Q1 | 21.12 Million USD | -11.13% |
| 2006 FY | 23.77 Million USD | -10.65% |
| 2006 Q1 | 22.26 Million USD | -16.3% |
| 2006 Q3 | 23.48 Million USD | 13.32% |
| 2006 Q4 | 23.77 Million USD | 1.22% |
| 2006 Q2 | 20.72 Million USD | -6.93% |
| 2005 Q1 | 37.58 Million USD | 67.0% |
| 2005 FY | 26.6 Million USD | 18.21% |
| 2005 Q4 | 26.6 Million USD | 17.29% |
| 2005 Q3 | 22.68 Million USD | 29.28% |
| 2005 Q2 | 17.54 Million USD | -53.31% |
| 2004 Q4 | 22.5 Million USD | 2.64% |
| 2004 Q3 | 21.92 Million USD | 3.6% |
| 2004 Q2 | 21.16 Million USD | -6.42% |
| 2004 Q1 | 22.61 Million USD | -18.18% |
| 2004 FY | 22.5 Million USD | -18.59% |
| 2003 Q3 | 21.76 Million USD | 21.61% |
| 2003 Q4 | 27.64 Million USD | 27.03% |
| 2003 FY | 27.64 Million USD | 39.36% |
| 2003 Q1 | 20.32 Million USD | 2.43% |
| 2003 Q2 | 17.89 Million USD | -11.93% |
| 2002 FY | 19.83 Million USD | -9.77% |
| 2002 Q4 | 19.83 Million USD | 19.13% |
| 2002 Q3 | 16.65 Million USD | -0.36% |
| 2002 Q2 | 16.71 Million USD | -2.6% |
| 2002 Q1 | 17.15 Million USD | -21.95% |
| 2001 Q4 | 21.98 Million USD | 2.19% |
| 2001 FY | 21.98 Million USD | -7.34% |
| 2001 Q2 | 19.41 Million USD | -11.41% |
| 2001 Q3 | 21.51 Million USD | 10.82% |
| 2001 Q1 | 21.91 Million USD | -7.65% |
| 2000 FY | 23.72 Million USD | 0.0% |
| 2000 Q1 | 23.33 Million USD | 0.0% |
| 2000 Q4 | 23.72 Million USD | 20.62% |
| 2000 Q2 | 22.23 Million USD | -4.73% |
| 2000 Q3 | 19.66 Million USD | -11.54% |
| 1999 Q3 | 16.4 Million USD | 164.52% |
| 1999 Q2 | 6.2 Million USD | -21.52% |
| 1999 Q1 | 7.9 Million USD | -11.24% |
| 1998 Q3 | 10 Million USD | 3.09% |
| 1998 Q4 | 8.9 Million USD | -11.0% |
| 1998 FY | 7.9 Million USD | -27.52% |
| 1998 Q1 | 10.9 Million USD | 25.29% |
| 1998 Q2 | 9.7 Million USD | -11.01% |
| 1997 Q1 | 7.1 Million USD | 1.43% |
| 1997 Q2 | 7.2 Million USD | 1.41% |
| 1997 FY | 10.9 Million USD | 53.52% |
| 1997 Q4 | 8.7 Million USD | 22.54% |
| 1997 Q3 | 7.1 Million USD | -1.39% |
| 1996 Q1 | 7.6 Million USD | -7.32% |
| 1996 FY | 7.1 Million USD | -6.58% |
| 1996 Q2 | 7.3 Million USD | -3.95% |
| 1996 Q3 | 6.8 Million USD | -6.85% |
| 1996 Q4 | 7 Million USD | 2.94% |
| 1995 Q4 | 8.2 Million USD | 2.5% |
| 1995 Q2 | 8.7 Million USD | -17.92% |
| 1995 Q3 | 8 Million USD | -8.05% |
| 1995 FY | 7.6 Million USD | -28.3% |
| 1995 Q1 | 10.6 Million USD | 4.95% |
| 1994 Q2 | 9.6 Million USD | -9.43% |
| 1994 Q4 | 10.1 Million USD | -4.72% |
| 1994 Q1 | 10.6 Million USD | 324.0% |
| 1994 Q3 | 10.6 Million USD | 10.42% |
| 1994 FY | 10.6 Million USD | 0.0% |
| 1993 Q3 | 2.1 Million USD | -76.67% |
| 1993 Q2 | 9 Million USD | -12.62% |
| 1993 Q1 | 10.3 Million USD | 10.75% |
| 1993 FY | 10.6 Million USD | 2.91% |
| 1993 Q4 | 2.5 Million USD | 19.05% |
| 1992 Q3 | 9.5 Million USD | 6.74% |
| 1992 FY | 10.3 Million USD | 7.29% |
| 1992 Q1 | 9.6 Million USD | 1.05% |
| 1992 Q2 | 8.9 Million USD | -7.29% |
| 1992 Q4 | 9.3 Million USD | -2.11% |
| 1991 Q1 | 15.5 Million USD | 0.0% |
| 1991 Q3 | 10 Million USD | -13.04% |
| 1991 Q2 | 11.5 Million USD | -25.81% |
| 1991 Q4 | 9.5 Million USD | -5.0% |
| 1991 FY | 9.6 Million USD | -38.06% |
| 1990 Q1 | 6.4 Million USD | 0.0% |
| 1990 FY | 15.5 Million USD | 142.19% |
| 1989 FY | 6.4 Million USD | 3.23% |
| 1989 Q1 | 6.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -2709.817% |
| AngioDynamics, Inc. | 112.08 Million USD | -3073.663% |
| AtriCure, Inc. | 147.76 Million USD | -2307.352% |
| Avinger, Inc. | 19.97 Million USD | -17710.935% |
| Azenta, Inc. | 351.22 Million USD | -912.812% |
| BioLife Solutions, Inc. | 75.05 Million USD | -4639.71% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 13.406% |
| Daxor Corporation | 858.75 Thousand USD | -414126.127% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -21707.258% |
| Femasys Inc. | 9.4 Million USD | -37729.53% |
| GlucoTrack, Inc. | 1.7 Million USD | -208166.979% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -5432.881% |
| Hologic, Inc. | 4.02 Billion USD | 11.644% |
| ICU Medical, Inc. | 2.25 Billion USD | -57.745% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -74.014% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -43777.042% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -7177.712% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -538921.966% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -538921.966% |
| Masimo Corporation | 1.67 Billion USD | -112.155% |
| Microbot Medical Inc. | 3.82 Million USD | -92874.386% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -14084.855% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | -216.69% |
| Nephros, Inc. | 3.5 Million USD | -101447.245% |
| NovoCure Limited | 783.63 Million USD | -353.937% |
| NEXGEL, Inc. | 4.78 Million USD | -74178.555% |
| NEXGEL, Inc. | 4.78 Million USD | -74178.555% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -4014.225% |
| OraSure Technologies, Inc. | 52.17 Million USD | -6717.955% |
| Pro-Dex, Inc. | 23.34 Million USD | -15138.83% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -21532.208% |
| Predictive Oncology Inc. | 6.14 Million USD | -57783.296% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -51869.485% |
| Repligen Corporation | 853.2 Million USD | -316.921% |
| Sanara MedTech Inc. | 29.28 Million USD | -12047.608% |
| STAAR Surgical Company | 102.73 Million USD | -3362.4% |
| Sharps Technology, Inc. | 3.85 Million USD | -92175.398% |
| Utah Medical Products, Inc. | 7.14 Million USD | -49685.864% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 12.728% |
| Jin Medical International Ltd. | 8.92 Million USD | -39759.508% |